Characterization of the Human Immune Response to a Polysaccharide Vaccine from Pseudomonas aeruginosa

1983 ◽  
Vol 148 (2) ◽  
pp. 206-213 ◽  
Author(s):  
G. B. Pier ◽  
D. M. Thomas
2012 ◽  
Vol 189 (2) ◽  
pp. 935-945 ◽  
Author(s):  
Larissa N. A. Longhi ◽  
Rosiane M. da Silva ◽  
Márcia C. Fornazim ◽  
Maria C. Spago ◽  
Rômulo T. D. de Oliveira ◽  
...  

Vaccine ◽  
1999 ◽  
Vol 17 (2) ◽  
pp. 158-168 ◽  
Author(s):  
In-Jin Jang ◽  
Ik-Sang Kim ◽  
Wan Je Park ◽  
Kyung-Sang Yoo ◽  
Dong-Suk Yim ◽  
...  

1994 ◽  
Vol 62 (9) ◽  
pp. 3972-3979 ◽  
Author(s):  
G B Pier ◽  
D DesJardin ◽  
M Grout ◽  
C Garner ◽  
S E Bennett ◽  
...  

2004 ◽  
Vol 42 (2) ◽  
pp. 267-270 ◽  
Author(s):  
Les Baillie ◽  
Tim Townend ◽  
Nicki Walker ◽  
Ulla Eriksson ◽  
Diane Williamson

2021 ◽  
Vol 27 (4) ◽  
pp. 571-572 ◽  
Author(s):  
Roberto Burioni ◽  
Eric J. Topol

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Diane Williamson

This review considers the steps required to evaluate a candidate biodefense vaccine or therapy as it emerges from the research phase, in order to transition it to development. The options for preclinical modelling of efficacy are considered in the context of the FDA’s Animal Rule.


1989 ◽  
Vol 21 (4) ◽  
pp. 386???392 ◽  
Author(s):  
LEONARD H. CALABRESE ◽  
SUSAN M. KLEINER ◽  
BARBARA P. BARNA ◽  
CHRISTINE I. SKIBINSKI ◽  
DONALD T. KIRKENDALL ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document